Why the study?
Does allogeneic MSC implantation improve long-term cardiac function in infarcted rat myocardia compared to syngeneic MSCs or media?
Population
Infarcted rat myocardia (in vivo) and mesenchymal stem cells (in vitro)
Comparison
Allogeneic mesenchymal stem cells implantation vs Syngeneic MSCs or media
Design
Preclinical
Follow-up
6 months
Authors
Loading...
Transient benefits in rat MI models do not support clinical adoption; leaves open durability and immunogenicity barriers for translation.
Does allogeneic MSC implantation improve long-term cardiac function in infarcted rat myocardia compared to syngeneic MSCs or media?
Allogeneic MSCs lose their immunoprivilege upon differentiation, leading to immune rejection and loss of long-term functional benefits in myocardial repair.
Huang et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: